Complement activation during blood sampling procedures alters the expression of CD11b/CD18 on human neutrophils

Vox Sanguinis

Volumn 74, Issue 1, 1998, Pages 21-26

  Wehlin, L ^a   Gustavsson, K ^a   Hallden G ^a   Emilson, A ^a   Svensson, A ^a   Hild, M ^a   Lundahl, J ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD18 ANTIGEN; COMPLEMENT; EDETIC ACID; EOSINOPHIL CATIONIC PROTEIN;

ARTICLE; BLOOD SAMPLING; CELL SEPARATION; COMPLEMENT ACTIVATION; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; EOSINOPHIL; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL; SERUM; TUBE;

ANTIGENS, CD18; BLOOD PROTEINS; BLOOD SPECIMEN COLLECTION; COMPLEMENT ACTIVATION; COMPLEMENT C3C; EOSINOPHIL GRANULE PROTEINS; EOSINOPHILS; HUMANS; INFLAMMATION MEDIATORS; MACROPHAGE-1 ANTIGEN; NEUTROPHILS; PLASMA; PLASTICS; RIBONUCLEASES;

EID: 0031982927     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1159/000030897     Document Type: Article

References (23)

1. Springer TA: Adhesion receptors of the immune system. Nature 1990;346:425-434.
2. Fällman M, Andersson R, Andersson T. Signaling properties of CR3 (CD11b/CD18) and CR1 (CD35) in relation to phagocytosis of complement opsonized particles. J Immunol 1993;151: 330-338.
3. Calafat J, Kuijpers TW, Janssen H, Borregaard N, Verhoeven AJ, Roos D: Evidence for small intracellular vesicles in human blood phagocytes containing cytochrome b558 and the adhesion molecule CD11b/CD18. Blood 1993;11: 3122-3129.
4. Bosquet J, Chanez P, Lacoste J. Barnéon G, Ghavanian N, Enander I, Venge P, Ahlstedt S, Simony-Lafonte J, Godard P, Michel FB: Eosinophilic inflammation in asthma. N Engl J Med 1990;323:1033-1039.
5. Skedinger M, Halldén G, Lundahl J, Hed J, Zetterström O: Eosinophil activity reflects clinical status in patients with asthma before and during a prednisolone course. Am Allergy Asthma Immunol 1995;75:250-255.
6. Buyon JP, Shadick N, Berkman R, Hopkins P, Dalton J, Weissmann G, Winchester R, Abramson SB: Surface expression of Gp 165/95, the complement receptor type 3, CR3, as a marker of disease activity in systemic lupus erythematosus. Clin Immunol Immunopathol 1988;46: 141-148.
7. Arm JP, Walport MJ, Lee TH: Expression of complement receptors type l (CR1) and type 3 (CR3) on circulating granulocytes in experimentally provoked asthma. J Allergy Clin Immunol 1989;83:649-655.
8. Thylén P, Lundahl J, Fernvik E, Hed J, Svensson SB, Jacobsson SH: Mobilization of an intracellular glycoprotein (Mac-1) on monocytes and granulocytes during hemodialysis. Am J Nephrol 1992;12:393-400.
9. Lundahl J, Halldén G, Hallgren M, Sköld CM, Hed J: Altered expression of CD11b/CD18 and CD62L on human monocytes after cell preparation procedures. J Immunol Methods 1995; 180: 93-100.
10. Hed J, Berg O, Forslid J, Halldén G, Lärka-Raffner G: The expression of CR1 and CR3 on non-modulated and modulated granulocytes of healthy blood donors as measured by flow cytofluorometry. Scand J Immunol 1988;28:339-344.
11. Truedsson L, Sjöholm AG, Laurell AL: Screening for deficiency in the classical and alternative pathways of complement activation by hemolysis in gel. Acta Pathol Microbiol Scand 1981;89:C161-C165.
12. Halldén G, Andersson U, Hed J, Johansson SGO: A new membrane permeabilization method for the detection of intracellular antigens by flow cytometry. J Immunol Methods 1989;124:103-109.
13. Halldén G, Hed J: The FOG method, a new approach to detecting activated eosinophils. Allergy Clin Immunol News 1993;5:139-143.
14. Hed J, Halldén G: Counts of activated blood eosinophils for monitoring asthma. Allergy 1993; 48:87-93.
15. Scheynius A, Emilson A, van Hage-Hamsten M: Confocal laser scanning microscopy in the study of allergens and Langerhans' cells. Allergy Clin Immunol News 1993;5:135-138.
16. Miller LJ, Bainton DF, Borregaard N, Springer TA: Stimulated mobilization of monocyte Mac-1 and p 150.95 adhesion proteins from an intracellular vesicular compartment to the cell surface. J Clin Invest 1987;80:535-544.
17. Fearon D, Collins L: Increased expression of C3b receptors on polymorphonuclear leukocytes induced by chemotactic factors and by purification procedures. J Immunol 1983;130: 370-375.
18. Kuijpers TW, Tool ATJ, van der Schoot CE, Ginsel LA, Underwater JJM, Roos D, Verhoeven AJ: Membrane surface antigen expression on neutrophils: A reappraisal of the use of surface markers for neutrophil activation. Blood 1991;78:1105-1111.
19. Macey MG, Jiang XP, Veys P, McCarthy D, Newland AC: Expression of functional antigens on neutrophils. Effects of preparation. J Immunol Methods 1992;149:37-42.
20. Law SKA, Reid KBM: Complement. Oxford, IRL Press, 1988, pp 1-67.
21. Mollnes TE, Garred P, Bergseth G: Effect of time, temperature and anticoagulants on in vitro complement activation: Consequences for collection and preservation of samples to be examined for complement activation. Clin Exp Immunol 1988;73:484-488.
22. Kernen P, Wymann MP, von Tscharner V, Deranleau DA, Tai PC, Spry CJ, Dahinden CA, Baggiolini M: Shape changes, exocytosis and cytosolic free calcium changes in stimulated human eosinophils. J Clin Invest 1991;87:2012-2017.
23. Gerard NP, Hodges MK, Drazen JM, Weller PF, Gerard C: Characterization of a receptor for C5a anaphylatoxin on human eosinophils. J Biol Chem 1989;264:1760-1766.